INGN
Price
$10.78
Change
+$0.10 (+0.94%)
Updated
Sep 19, 10:20 AM (EDT)
47 days until earnings call
VCYT
Price
$34.90
Change
+$1.14 (+3.38%)
Updated
Sep 19, 10:59 AM (EDT)
47 days until earnings call
Ad is loading...

INGN vs VCYT

Header iconINGN vs VCYT Comparison
Open Charts INGN vs VCYTBanner chart's image
Inogen
Price$10.78
Change+$0.10 (+0.94%)
Volume$300
CapitalizationN/A
Veracyte
Price$34.90
Change+$1.14 (+3.38%)
Volume$600
CapitalizationN/A
View a ticker or compare two or three
INGN vs VCYT Comparison Chart
Loading...
INGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
INGN vs. VCYT commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INGN is a Hold and VCYT is a StrongBuy.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (INGN: $10.70 vs. VCYT: $33.76)
Brand notoriety: INGN and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INGN: 110% vs. VCYT: 113%
Market capitalization -- INGN: $176.12M vs. VCYT: $1.66B
INGN [@Medical Specialties] is valued at $176.12M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INGN’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • INGN’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than INGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INGN’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 5 bullish TA indicator(s).

  • INGN’s TA Score: 4 bullish, 5 bearish.
  • VCYT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than INGN.

Price Growth

INGN (@Medical Specialties) experienced а -7.44% price change this week, while VCYT (@Medical Specialties) price change was +11.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.94%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was -2.55%.

Reported Earning Dates

INGN is expected to report earnings on Nov 05, 2024.

VCYT is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Medical Specialties (+1.94% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than INGN($176M). INGN YTD gains are higher at: 94.900 vs. VCYT (22.719). VCYT has higher annual earnings (EBITDA): -49.41M vs. INGN (-58.34M). VCYT has more cash in the bank: 216M vs. INGN (128M). VCYT has less debt than INGN: VCYT (12.6M) vs INGN (21.9M). VCYT has higher revenues than INGN: VCYT (361M) vs INGN (316M).
INGNVCYTINGN / VCYT
Capitalization176M1.66B11%
EBITDA-58.34M-49.41M118%
Gain YTD94.90022.719418%
P/E Ratio71.43N/A-
Revenue316M361M88%
Total Cash128M216M59%
Total Debt21.9M12.6M174%
FUNDAMENTALS RATINGS
INGN vs VCYT: Fundamental Ratings
INGN
VCYT
OUTLOOK RATING
1..100
5511
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
10083
SMR RATING
1..100
9792
PRICE GROWTH RATING
1..100
3837
P/E GROWTH RATING
1..100
71100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (41) in the Biotechnology industry is somewhat better than the same rating for INGN (78) in the Medical Specialties industry. This means that VCYT’s stock grew somewhat faster than INGN’s over the last 12 months.

VCYT's Profit vs Risk Rating (83) in the Biotechnology industry is in the same range as INGN (100) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to INGN’s over the last 12 months.

VCYT's SMR Rating (92) in the Biotechnology industry is in the same range as INGN (97) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to INGN’s over the last 12 months.

VCYT's Price Growth Rating (37) in the Biotechnology industry is in the same range as INGN (38) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to INGN’s over the last 12 months.

INGN's P/E Growth Rating (71) in the Medical Specialties industry is in the same range as VCYT (100) in the Biotechnology industry. This means that INGN’s stock grew similarly to VCYT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INGNVCYT
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 24 days ago
72%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
N/A
View a ticker or compare two or three
Ad is loading...
INGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCSCX22.37N/A
N/A
Goldman Sachs Small Cap Eq Insghts C
TAISX11.27-0.02
-0.18%
Nuveen Quant Intl Small Cap Eq I
RPBAX28.03-0.08
-0.28%
T. Rowe Price Balanced
WAISX12.15-0.05
-0.41%
Wasatch International Select Investor
RYELX377.99-3.88
-1.02%
Rydex Electronics A

INGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INGN
1D Price
Change %
INGN100%
-1.29%
VCYT - INGN
46%
Loosely correlated
-1.63%
MYGN - INGN
40%
Loosely correlated
-0.56%
SNN - INGN
38%
Loosely correlated
-0.81%
KIDS - INGN
38%
Loosely correlated
-3.28%
AVNS - INGN
37%
Loosely correlated
+0.25%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
-1.63%
NTLA - VCYT
69%
Closely correlated
-0.13%
VCEL - VCYT
60%
Loosely correlated
+4.58%
AXON - VCYT
58%
Loosely correlated
+0.15%
DNA - VCYT
57%
Loosely correlated
+8.81%
ABCL - VCYT
55%
Loosely correlated
+0.73%
More